CAPGEMINI UNS.ADR 1/5/EO8 (CGMA) - Net Assets
Based on the latest financial reports, CAPGEMINI UNS.ADR 1/5/EO8 (CGMA) has net assets worth €11.67 Billion EUR (≈ $13.65 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€29.06 Billion ≈ $33.97 Billion USD) and total liabilities (€17.39 Billion ≈ $20.33 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check CAPGEMINI UNS.ADR 1/5/EO8 (CGMA) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €11.67 Billion |
| % of Total Assets | 40.17% |
| Annual Growth Rate | 6.2% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 5.65 |
CAPGEMINI UNS.ADR 1/5/EO8 - Net Assets Trend (2022–2025)
This chart illustrates how CAPGEMINI UNS.ADR 1/5/EO8's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of CAPGEMINI UNS.ADR 1/5/EO8 for the complete picture of this company's asset base.
Annual Net Assets for CAPGEMINI UNS.ADR 1/5/EO8 (2022–2025)
The table below shows the annual net assets of CAPGEMINI UNS.ADR 1/5/EO8 from 2022 to 2025. For live valuation and market cap data, see CAPGEMINI UNS.ADR 1/5/EO8 market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €11.67 Billion ≈ $13.65 Billion |
-1.06% |
| 2024-12-31 | €11.80 Billion ≈ $13.79 Billion |
+12.64% |
| 2023-12-31 | €10.47 Billion ≈ $12.24 Billion |
+7.49% |
| 2022-12-31 | €9.74 Billion ≈ $11.39 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to CAPGEMINI UNS.ADR 1/5/EO8's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 57.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €7.31 Billion | 62.72% |
| Other Components | €4.34 Billion | 37.28% |
| Total Equity | €11.65 Billion | 100.00% |
CAPGEMINI UNS.ADR 1/5/EO8 Competitors by Market Cap
The table below lists competitors of CAPGEMINI UNS.ADR 1/5/EO8 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Essex Property Trust Inc
NYSE:ESS
|
$16.97 Billion |
|
ASICS CORP.(UNSP.ADR)/1
F:ASI
|
$17.00 Billion |
|
Rentokil Initial PLC
NYSE:RTO
|
$17.00 Billion |
|
BizLink Holding Inc
TW:3665
|
$17.01 Billion |
|
Taishin Financial Holding Co Ltd Pref
TW:2887E
|
$16.93 Billion |
|
JIO Financial Services Ltd
NSE:JIOFIN
|
$16.93 Billion |
|
Formosa Petrochemical Corp
TW:6505
|
$16.93 Billion |
|
AIRTEL AFRICA UNSP.ADR/10
F:9AA0
|
$16.88 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CAPGEMINI UNS.ADR 1/5/EO8's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 11,775,000,000 to 11,648,000,000, a change of -127,000,000 (-1.1%).
- Net income of 1,601,000,000 contributed positively to equity growth.
- Dividend payments of 581,000,000 reduced retained earnings.
- Share repurchases of 543,000,000 reduced equity.
- New share issuances of 297,000,000 increased equity.
- Other factors decreased equity by 901,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €1.60 Billion | +13.74% |
| Dividends Paid | €581.00 Million | -4.99% |
| Share Repurchases | €543.00 Million | -4.66% |
| Share Issuances | €297.00 Million | +2.55% |
| Other Changes | €-901.00 Million | -7.74% |
| Total Change | €- | -1.08% |
Book Value vs Market Value Analysis
This analysis compares CAPGEMINI UNS.ADR 1/5/EO8's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.30x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-12-31 | €56.58 | €20.60 | x |
| 2023-12-31 | €61.03 | €20.60 | x |
| 2024-12-31 | €69.28 | €20.60 | x |
| 2025-12-31 | €69.20 | €20.60 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CAPGEMINI UNS.ADR 1/5/EO8 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 13.74%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.13%
- • Asset Turnover: 0.77x
- • Equity Multiplier: 2.49x
- Recent ROE (13.74%) is below the historical average (14.94%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | 15.90% | 7.03% | 0.86x | 2.62x | €574.30 Million |
| 2023 | 15.91% | 7.38% | 0.91x | 2.36x | €617.60 Million |
| 2024 | 14.19% | 7.56% | 0.86x | 2.18x | €493.50 Million |
| 2025 | 13.74% | 7.13% | 0.77x | 2.49x | €436.20 Million |
Industry Comparison
This section compares CAPGEMINI UNS.ADR 1/5/EO8's net assets metrics with peer companies in the Information Technology Services industry.
Industry Context
- Industry: Information Technology Services
- Average net assets among peers: $372,308,104
- Average return on equity (ROE) among peers: -26.76%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CAPGEMINI UNS.ADR 1/5/EO8 (CGMA) | €11.67 Billion | 15.90% | 1.49x | $16.96 Billion |
| CLPS INC. DL-0001 (1UK) | $65.51 Million | 0.29% | 0.46x | $22.08 Million |
| Globant SA (2G2) | $2.03 Billion | 8.15% | 0.56x | $1.81 Billion |
| Solutions 30 SE (30L3) | $138.35 Million | 28.35% | 3.65x | $73.59 Million |
| Genpact Limited (35G) | $1.42 Billion | 18.32% | 1.42x | $5.38 Billion |
| NANOSPHERE (3NS) | $-1.44 Million | 0.00% | 0.00x | $1.14 Million |
| CPT GLOBAL LTD (714) | $5.63 Million | 26.15% | 1.60x | $2.11 Million |
| PASSUS S.A. ZY-1 (71X) | $24.32 Million | 6.67% | 2.00x | $57.96 Million |
| REVEZ CORPORATION LTD. (7IQ) | $1.32 Million | -332.24% | 3.80x | $131.66K |
| XTM INC. (7XT) | $-7.33 Million | 0.00% | 0.00x | $1.23 Million |
| TPXIMPACT HOLDINGS LS-01 (9L7) | $39.33 Million | -23.28% | 0.70x | $35.61 Million |
About CAPGEMINI UNS.ADR 1/5/EO8
Capgemini SE, together with its subsidiaries, provides consulting, digital transformation, technology, and engineering services primarily in North America, France, the United Kingdom, Ireland, the rest of Europe, the Asia-Pacific, and Latin America. It offers strategy and transformation services in strategy, technology, engineering, data science, and creative design fields to support companies an… Read more